Harnessing mitophagy for intervertebral disc degeneration: a paradigm shift in targeted therapeutics

Read full text Summarise with VIRAT
Authors: Yang Hou, Mingjian Sun, Lei Liu, Tianyi Zhao, Ji‐Xin Shi, Yongfei Guo
Cited by: 0
References: 117

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Intervertebral disc degeneration (IDD) is a leading cause of chronic low back pain worldwide. It involves degenerative changes in nucleus pulposus, annulus fibrosus, and cartilage endplate cells, driven by factors such as oxidative stress, inflammation, mechanical imbalance, and apoptosis. Mitochondrial dysfunction lies at the heart of IDD progression, marked by excessive reactive oxygen species, reduced ATP production, and compromised cellular homeostasis. Mitophagy, the selective autophagic clearance of damaged mitochondria, emerges as a key regulator of mitochondrial quality control. Canonical pathways including those involving PINK1–PRKN/Parkin, BNIP3 and BNIP3L/NIX, as well as non-canonical mechanisms involving PHB2 and cardiolipin, coordinate the removal of dysfunctional mitochondria. However, dysregulated mitophagy in IDD can spur persistent oxidative stress, chronic inflammation, and cell death in different disc cell types, thereby hastening tissue degeneration. Therapeutic strategies focusing on mitophagy modulation include small-molecule agents, gene therapy targeting key mitophagy regulators, and stem cell treatments that restore mitochondrial function. Despite promising preclinical findings, challenges remain, particularly in achieving specificity and safety, as well as translating these approaches into effective clinical interventions. Future efforts integrating multi-omics analyses, refined animal models, and gene-editing tools may deepen our understanding of mitophagy’s role in IDD and pave the way for novel, targeted therapies aimed at improving patient outcomes.

Fields of Study & Subjects

Spine and Intervertebral Disc Pathology Autophagy in Disease and Therapy Cervical and Thoracic Myelopathy

Publication details

Journal / source
Advances in Redox Research
Volume
19
Pages
100164–100164
Publication date
25 March 2026
Language
EN